An App-Based Just-in-Time Adaptive Self-management Intervention for Care Partners (CareQOL): Protocol for a Pilot Trial (Preprint)
Preprint
- 11 August 2021
- preprint
- Published by JMIR Publications Inc. in JMIR Preprints
Abstract
BACKGROUND Care partners (ie, informal family caregivers) of individuals with health problems face considerable physical and emotional stress, often with a substantial negative impact on the health-related quality of life (HRQOL) of both care partners and care recipients. Given that these individuals are often overwhelmed by their caregiving responsibilities, low-burden self-management interventions are needed to support care partners to ensure better patient outcomes. OBJECTIVE The primary objective of this study is to describe an intensive data collection protocol that involves the delivery of a personalized just-in-time adaptive intervention that incorporates passive mobile sensor data feedback (sleep and activity data from a Fitbit [Fitbit LLC]) and real time self-reporting of HRQOL via a study-specific app called CareQOL (University of Michigan) to provide personalized feedback via app alerts. METHODS Participants from 3 diverse care partner groups will be enrolled (care partners of persons with spinal cord injury, care partners of persons with Huntington disease, and care partners of persons with hematopoietic cell transplantation). Participants will be randomized to either a control group, where they will wear the Fitbit and provide daily reports of HRQOL over a 3-month (ie, 90 days) period (without personalized feedback), or the just-in-time adaptive intervention group, where they will wear the Fitbit, provide daily reports of HRQOL, and receive personalized push notifications for 3 months. At the end of the study, participants will complete a feasibility and acceptability questionnaire, and metrics regarding adherence and attrition will be calculated. RESULTS This trial opened for recruitment in November 2020. Data collection was completed in June 2021, and the primary results are expected to be published in 2022. CONCLUSIONS This trial will determine the feasibility and acceptability of an intensive app-based intervention in 3 distinct care partner groups: care partners for persons with a chronic condition that was caused by a traumatic event (ie, spinal cord injury); care partners for persons with a progressive, fatal neurodegenerative disease (ie, Huntington disease); and care partners for persons with episodic cancer conditions that require intense, prolonged inpatient and outpatient treatment (persons with hematopoietic cell transplantation). CLINICALTRIAL ClinicalTrials.gov NCT04556591; https://clinicaltrials.gov/ct2/show/NCT04556591 INTERNATIONAL REGISTERED REPORT DERR1-10.2196/32842Keywords
All Related Versions
- Published version: JMIR Research Protocols, 10 (12), e32842.
This publication has 111 references indexed in Scilit:
- Elevated peri‐transplant distress in caregivers of allogeneic blood or marrow transplant patientsPsycho-Oncology, 2013
- Huntington’s disease from the patient, caregiver and physician’s perspectives: three sides of the same coin?Journal of Neural Transmission, 2012
- Caregiving Burden, Stress, and Health Effects Among Family Caregivers of Adult Cancer PatientsJAMA, 2012
- Smoking cessation support delivered via mobile phone text messaging (txt2stop): a single-blind, randomised trialThe Lancet, 2011
- Measuring Participation: The Patient-Reported Outcomes Measurement Information System ExperienceArchives of Physical Medicine and Rehabilitation, 2010
- Continuous Glucose Monitoring and Intensive Treatment of Type 1 DiabetesNew England Journal of Medicine, 2008
- The symptom experience in the first 100 days following allogeneic hematopoietic stem cell transplantation (HSCT)Supportive Care in Cancer, 2008
- The Patient-Reported Outcomes Measurement Information System (PROMIS)Medical Care, 2007
- Patient outcome in the year following severe head injury and relatives' psychiatric and social functioning.Journal of Neurology, Neurosurgery & Psychiatry, 1985
- Termination of Malignant Ventricular Arrhythmias with an Implanted Automatic Defibrillator in Human BeingsNew England Journal of Medicine, 1980